Jeremy Scarlett, MD
Pain Medicine · Sheboygan, WINPI 1992737589
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by Si-bone, Inc. at 32.7% of the total. Reporting peaked in 2024 at $14,356 and has fallen 59.3% since, to $5,850 in 2025. Among pain medicine clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 822 payments — averaging $49.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$13K
- Medtronic$6K
- Spinal Simplicity, LLC$3K
- Nevro Corp.$3K
- Abbott$2K
- SPR Therapeutics, Inc$2K
- plus $12K from 43 others
Across 2 payments — averaging $232.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$410
- Saluda Medical Americas, Inc.$55
What the payments were for
- Consulting fees$12,32030%
- Travel & lodging$4,43811%
- Food & beverage$23,62358%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$11,744
- HA MINUTEMAN G3-R$2,204
- SACROILIAC JOINT FUSION SYSTEM$1,914
- Senza Spinal Cord Stimulation System$1,054
- INTELLIS$1,037
- SYNCHROMED$990
- SPRINT PNS System$805
- Proclaim Family of SCS IPGs$600
- Evoke$560
- Senza$480
- Omnia$446
- INTELLIS ADAPTIVESTIM$416
- ETERNA$341
- VANTA ADAPTIVESTIM$302
- SYNCHROMEDII$297
- PROCLAIM$268
- UBRELVY$250
- mild Device Kit$198
- Stimrouter for pain$182
- INCEPTIV$175
How this compares
$40,396 in reported general payments places this provider in the 90th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 47 | $37,203 |
| Xtampza ErOxycodone Myristate | 54 | $26,612 |
| BelbucaBuprenorphine Hcl | 40 | $25,176 |
| UbrelvyUbrogepant | 11 | $16,220 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 281 | $5,130 |
| Buprenorphine | 32 | $4,806 |
| OxycontinOxycodone Hcl | 11 | $3,997 |
| Gabapentin | 142 | $2,606 |
| Pregabalin | 70 | $2,171 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 127 | $1,885 |
| Oxycodone Hcl | 112 | $1,698 |
| Tizanidine Hcl | 70 | $1,036 |
| Fentanyl | 12 | $1,011 |
| Duloxetine Hcl | 41 | $916 |
| Morphine Sulfate ErMorphine Sulfate | 44 | $831 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er, Belbuca | $910 | $88,992141 claims |
| AbbVieUbrelvy | $1,327 | $16,22011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 82 pain medicine providers in Wisconsin.
Other pain medicine in Sheboygan
- Atit ShahSheboygan$76K
- John PetersSheboygan$18K
- Alaa Abd-ElsayedMadison$1.3M
- Michael JungWest Bend$339K
- Frederick FreitagMadison$157K
- Thomas FaullMadison$66K
- Ammar MahmoudNeenah$57K
- Thomas StaussGreenfield$34K
- Matthew FischerAppleton$21K
- Jeffrey QuintanaMilwaukee$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.